Tidal Trust III - VistaShares Artificial Intelligence Supercycle ETF
US ˙ ARCA

Introdução

Esta página fornece uma análise abrangente do histórico conhecido de negociações internas de Deerfield International Master Fund, L.P.. Insiders são oficiais, diretores ou investidores significativos em uma empresa. É ilegal para insiders realizarem negociações em suas próprias empresas baseados em informações específicas, não públicas. Isso não significa que seja ilegal para eles realizarem qualquer negociação em suas próprias empresas. No entanto, eles devem reportar todas as negociações à SEC através de um Formulário 4. Apesar dessas restrições, pesquisas acadêmicas sugerem que insiders - em geral - tendem a superar o mercado em suas próprias empresas.

Rentabilidade Média de Negociação

A rentabilidade média de negociação é o retorno médio de todas as compras de mercado abertas feitas pelo insider nos últimos três anos. Para calcular isso, examinamos cada compra de mercado aberto, não planejada, feita pelo insider, excluindo todas as negociações que foram marcadas como parte de um plano de negociação 10b5-1. Em seguida, calculamos o desempenho médio dessas negociações ao longo de 3, 6 e 12 meses, fazendo a média de cada uma dessas durações para gerar uma métrica de desempenho final para cada negociação. Finalmente, fazemos a média de todas as métricas de desempenho para calcular uma métrica de desempenho para o insider. Esta lista inclui apenas insiders que fizeram pelo menos três negociações nos últimos dois anos.

Se a rentabilidade de negociação deste insider é "N/A", então o insider ou não fez quaisquer compras de mercado aberto nos últimos três anos, ou as negociações que eles fizeram são muito recentes para calcular uma métrica de desempenho confiável.

Frequência de Atualização: Diariamente

Veja a lista dos negociantes internos mais rentáveis.

Empresas com Posições Internas Reportadas

As declarações à SEC indicam que Deerfield International Master Fund, L.P. reportou posses ou negociações nas seguintes empresas:

Ativo Título Últimas Posições Reportadas
US:PRTO / Tidal Trust Iii - Rcn Pareto Strategic Allocation Etf 10% Owner 0
US:REPH / Societal CDMO Inc 10% Owner 1,176,685
US:EHTH / eHealth, Inc. 10% Owner 877,606
US:VNDA / Vanda Pharmaceuticals Inc. 10% Owner 693,171
US:ZFGN / Zafgen, Inc. 10% Owner 1,151,802
US:XNPT / XenoPort, Inc. 10% Owner 2,746,650
US:AVXS / AveXis, Inc. 10% Owner 0
US:ATRS / Antares Pharma Inc 10% Owner 5,348,776
US:RGNX / REGENXBIO Inc. 10% Owner 0
US:ASPX / Auspex Pharmaceuticals, Inc. 10% Owner 0
US:AUXL / Auxilium Pharmaceuticals Inc 10% Owner 0
US:LOXO / Loxo Oncology, Inc. 10% Owner 0
US:AAVL / Avalanche Biotechnologies, Inc. 10% Owner 0
Como Interpretar os Gráficos

Os gráficos a seguir mostram o desempenho das ações dos a ativos ubsequentes a cada transação de mercado aberto, não planejada feita por Deerfield International Master Fund, L.P.. Transações não planejadas são negociações que não foram feitas como parte de um plano de negociação 10b5-1. O desempenho das ações é representado como mudança percentual cumulativa no preço das ações. Por exemplo, se uma transação interna foi feita em 1 de janeiro de 2019, o gráfico mostrará a mudança percentual diária da segurança até o dia presente. Se o preço da ação passasse de $10 para $15 durante este período, a mudança percentual cumulativa no preço das ações seria de 50%. Uma mudança no preço de $10 para $20 seria de 100%, e uma mudança no preço de $10 para $5 seria de -50%.

Ultimamente, estamos tentando determinar quão estreitamente as negociações do interno correlacionam-se a retornos excessivos (positivos ou negativos) no preço da ação para ver se o interno está cronometrando suas transações para lucrar com informações internas. Considere a situação onde um interno estava fazendo isso. Nesta situação, esperaríamos (a) retornos positivos após compras, ou (b) retornos negativos após vendas. No caso de (a), o gráfico de COMPRA mostraria uma série de curvas ascendentes, indicando retornos positivos após cada transação de compra. No caso de (b), o gráfico de VENDA mostraria uma série de curvas descendentes, indicando retornos negativos após cada transação de venda.

No entanto, isso sozinho não é suficiente para tirar conclusões. Se, por exemplo, o preço da ação da empresa estivesse em uma escalada não cíclica ao longo de muitos anos, então esperaríamos que todos os gráficos pós-compra tivessem uma inclinação ascendente. Da mesma forma, declínios não cíclicos ao longo de muitos anos resultariam em gráficos pós-negociação inclinados para baixo. Nenhum desses gráficos sugeriria atividade de negociação interna.

O indicador mais forte seria uma situação em que o preço da ação fosse extremamente cíclico, e houvesse sinais positivos no gráfico de COMPRA e gráficos negativos no gráfico de VENDA. Esta situação seria altamente sugestiva de um interno que estava cronometrando transações para sua vantagem financeira.

Compras Internas AIS / Tidal Trust III - VistaShares Artificial Intelligence Supercycle ETF - Análise de Lucro de Curto Prazo

Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em AIS / Tidal Trust III - VistaShares Artificial Intelligence Supercycle ETF. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Máx
Preço em
Máx
Lucro
Máx ($)
Retorno Máx (%)
Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

AIS / Tidal Trust III - VistaShares Artificial Intelligence Supercycle ETF Insider Trades
Vendas Internas AIS / Tidal Trust III - VistaShares Artificial Intelligence Supercycle ETF - Análise de Perda de Curto Prazo

Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em AIS / Tidal Trust III - VistaShares Artificial Intelligence Supercycle ETF. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Mín
Preço em
Mín
Máxima Perda
Evitada ($)
Máxima Perda
Evitada (%)
2015-09-30 ATRS Flynn James E 59,248 1.6921 59,248 1.6921 100,254 168 0.7057 -58,442 -58.29
2015-09-30 ATRS Flynn James E 106,820 1.6921 106,820 1.6921 180,750
2015-09-30 ATRS Flynn James E 83,930 1.6921 83,930 1.6921 142,018
2015-09-29 ATRS Flynn James E 42,728 1.8100 42,728 1.8100 77,338
2015-09-29 ATRS Flynn James E 33,572 1.8100 33,572 1.8100 60,765
2015-09-29 ATRS Flynn James E 23,700 1.8100 23,700 1.8100 42,897
2015-09-29 ATRS Flynn James E 19,976 1.8208 19,976 1.8208 36,372
2015-09-29 ATRS Flynn James E 15,696 1.8208 15,696 1.8208 28,579
2015-09-29 ATRS Flynn James E 11,081 1.8208 11,081 1.8208 20,176
2015-09-29 ATRS Flynn James E 43,845 1.8300 43,845 1.8300 80,236
2015-09-29 ATRS Flynn James E 34,450 1.8300 34,450 1.8300 63,044
2015-09-28 ATRS Flynn James E 288,726 1.8019 288,726 1.8019 520,255
2015-09-28 ATRS Flynn James E 226,857 1.8019 226,857 1.8019 408,774
2015-09-28 ATRS Flynn James E 469,224 1.8147 469,224 1.8147 851,501
2015-09-28 ATRS Flynn James E 368,676 1.8147 368,676 1.8147 669,036
2015-07-20 ATRS Flynn James E 10,304 2.1100 10,304 2.1100 21,741
2015-07-20 ATRS Flynn James E 8,096 2.1100 8,096 2.1100 17,083
2015-07-20 ATRS Flynn James E 4,131 2.1200 4,131 2.1200 8,758
2015-07-20 ATRS Flynn James E 3,245 2.1200 3,245 2.1200 6,879
2015-07-20 ATRS Flynn James E 5,152 2.1300 5,152 2.1300 10,974
2015-07-20 ATRS Flynn James E 4,048 2.1300 4,048 2.1300 8,622
2015-07-20 ATRS Flynn James E 39,787 2.1431 39,787 2.1431 85,268
2015-07-20 ATRS Flynn James E 31,261 2.1431 31,261 2.1431 66,995
2015-07-17 ATRS Flynn James E 70,431 2.2032 70,431 2.2032 155,174
2015-07-17 ATRS Flynn James E 55,338 2.2032 55,338 2.2032 121,921
2015-07-08 ATRS Flynn James E 56,000 2.0450 56,000 2.0450 114,520
2015-07-08 ATRS Flynn James E 44,000 2.0450 44,000 2.0450 89,980
2015-07-08 ATRS Flynn James E 56,000 2.0550 56,000 2.0550 115,080
2015-07-08 ATRS Flynn James E 44,000 2.0550 44,000 2.0550 90,420
2015-07-08 ATRS Flynn James E 55,944 2.0450 55,944 2.0450 114,405
2015-07-08 ATRS Flynn James E 43,956 2.0450 43,956 2.0450 89,890
2015-07-08 ATRS Flynn James E 55,944 2.0550 55,944 2.0550 114,965
2015-07-08 ATRS Flynn James E 43,956 2.0550 43,956 2.0550 90,330
2015-07-08 ATRS Flynn James E 24,943 2.0666 24,943 2.0666 51,547
2015-07-08 ATRS Flynn James E 19,598 2.0666 19,598 2.0666 40,501
2015-07-07 ATRS Flynn James E 20,272 2.0800 20,272 2.0800 42,166
2015-07-07 ATRS Flynn James E 15,928 2.0800 15,928 2.0800 33,130
2015-07-07 ATRS Flynn James E 4,424 2.0850 4,424 2.0850 9,224
2015-07-07 ATRS Flynn James E 3,476 2.0850 3,476 2.0850 7,247
2015-07-07 ATRS Flynn James E 2,856 2.0850 2,856 2.0850 5,955
2015-07-07 ATRS Flynn James E 2,244 2.0850 2,244 2.0850 4,679
2015-07-07 ATRS Flynn James E 30,684 2.0904 30,684 2.0904 64,142
2015-07-07 ATRS Flynn James E 24,108 2.0904 24,108 2.0904 50,395
2015-07-07 ATRS Flynn James E 53,009 2.0977 53,009 2.0977 111,197
2015-07-07 ATRS Flynn James E 41,650 2.0977 41,650 2.0977 87,369
2015-07-06 ATRS Flynn James E 21,240 2.1189 21,240 2.1189 45,005
2015-07-06 ATRS Flynn James E 16,689 2.1189 16,689 2.1189 35,362
2015-07-06 ATRS Flynn James E 86,007 2.1216 86,007 2.1216 182,472
2015-07-06 ATRS Flynn James E 67,577 2.1216 67,577 2.1216 143,371
2015-07-01 ATRS Flynn James E 18,612 2.1017 18,612 2.1017 39,117
2015-07-01 ATRS Flynn James E 14,624 2.1017 14,624 2.1017 30,735
2015-07-01 ATRS Flynn James E 5,936 2.1100 5,936 2.1100 12,525
2015-07-01 ATRS Flynn James E 4,664 2.1100 4,664 2.1100 9,841
2015-06-30 ATRS Flynn James E 42,255 2.0773 42,255 2.0773 87,776
2015-06-30 ATRS Flynn James E 104,745 2.0773 104,745 2.0773 217,587
2015-06-30 ATRS Flynn James E 82,300 2.0773 82,300 2.0773 170,962
2015-06-30 ATRS Flynn James E 69,914 2.0848 69,914 2.0848 145,757
2015-06-30 ATRS Flynn James E 173,307 2.0848 173,307 2.0848 361,310
2015-06-30 ATRS Flynn James E 136,170 2.0848 136,170 2.0848 283,887
2015-06-29 ATRS Flynn James E 11,185 2.1762 11,185 2.1762 24,341
2015-06-29 ATRS Flynn James E 27,726 2.1762 27,726 2.1762 60,337
2015-06-29 ATRS Flynn James E 21,784 2.1762 21,784 2.1762 47,406
2015-06-26 ATRS Flynn James E 22,405 2.2508 22,405 2.2508 50,429
2015-06-26 ATRS Flynn James E 65,870 2.2508 65,870 2.2508 148,260
2015-06-26 ATRS Flynn James E 51,755 2.2508 51,755 2.2508 116,490
2015-06-26 ATRS Flynn James E 33,627 2.2378 33,627 2.2378 75,251
2015-06-26 ATRS Flynn James E 101,291 2.2378 101,291 2.2378 226,669
2015-06-26 ATRS Flynn James E 79,586 2.2378 79,586 2.2378 178,098
2015-06-23 ATRS Flynn James E 28,510 2.3490 28,510 2.3490 66,970
2015-06-23 ATRS Flynn James E 85,877 2.3490 85,877 2.3490 201,725
2015-06-23 ATRS Flynn James E 67,475 2.3490 67,475 2.3490 158,499
2015-06-22 ATRS Flynn James E 27,666 2.4064 27,666 2.4064 66,575
2015-06-22 ATRS Flynn James E 83,338 2.4064 83,338 2.4064 200,545
2015-06-22 ATRS Flynn James E 65,479 2.4064 65,479 2.4064 157,569
2015-06-19 ATRS Flynn James E 22,190 2.4056 22,190 2.4056 53,380
2015-06-19 ATRS Flynn James E 66,842 2.4056 66,842 2.4056 160,795
2015-06-19 ATRS Flynn James E 52,518 2.4056 52,518 2.4056 126,337
2015-06-18 ATRS Flynn James E 32,419 2.4756 32,419 2.4756 80,256
2015-06-18 ATRS Flynn James E 97,654 2.4756 97,654 2.4756 241,752
2015-06-18 ATRS Flynn James E 76,728 2.4756 76,728 2.4756 189,948
2015-06-18 ATRS Flynn James E 611 2.4800 611 2.4800 1,515
2015-06-18 ATRS Flynn James E 1,842 2.4800 1,842 2.4800 4,568
2015-06-18 ATRS Flynn James E 1,447 2.4800 1,447 2.4800 3,589
2015-06-17 ATRS Flynn James E 8,403 2.4053 8,403 2.4053 20,212
2015-06-17 ATRS Flynn James E 25,313 2.4053 25,313 2.4053 60,885
2015-06-17 ATRS Flynn James E 19,889 2.4053 19,889 2.4053 47,839
2015-06-16 ATRS Flynn James E 15,175 2.4035 15,175 2.4035 36,473
2015-06-16 ATRS Flynn James E 45,710 2.4035 45,710 2.4035 109,864
2015-06-16 ATRS Flynn James E 35,915 2.4035 35,915 2.4035 86,322
2015-06-16 ATRS Flynn James E 18,382 2.4021 18,382 2.4021 44,155
2015-06-16 ATRS Flynn James E 55,372 2.4021 55,372 2.4021 133,009
2015-06-16 ATRS Flynn James E 43,506 2.4021 43,506 2.4021 104,506
2015-06-15 ATRS Flynn James E 4,722 2.4050 4,722 2.4050 11,356
2015-06-15 ATRS Flynn James E 3,710 2.4050 3,710 2.4050 8,923
2015-06-15 ATRS Flynn James E 15,866 2.4000 15,866 2.4000 38,078
2015-06-15 ATRS Flynn James E 12,467 2.4000 12,467 2.4000 29,921
2015-06-15 ATRS Flynn James E 69,198 2.4004 69,198 2.4004 166,103
2015-06-15 ATRS Flynn James E 54,370 2.4004 54,370 2.4004 130,510
2015-06-15 ATRS Flynn James E 1,568 2.4050 1,568 2.4050 3,771
2015-06-15 ATRS Flynn James E 5,267 2.4000 5,267 2.4000 12,641
2015-06-15 ATRS Flynn James E 22,973 2.4004 22,973 2.4004 55,144
2015-06-12 ATRS Flynn James E 7,838 2.4250 7,838 2.4250 19,007
2015-06-12 ATRS Flynn James E 7,838 2.4250 7,838 2.4250 19,007
2015-06-12 ATRS Flynn James E 18,595 2.4284 18,595 2.4284 45,156
2015-06-12 ATRS Flynn James E 23,611 2.4250 23,611 2.4250 57,257
2015-06-12 ATRS Flynn James E 18,551 2.4250 18,551 2.4250 44,986
2015-06-12 ATRS Flynn James E 23,611 2.4250 23,611 2.4250 57,257
2015-06-12 ATRS Flynn James E 18,551 2.4250 18,551 2.4250 44,986
2015-06-12 ATRS Flynn James E 56,012 2.4284 56,012 2.4284 136,020
2015-06-12 ATRS Flynn James E 44,010 2.4284 44,010 2.4284 106,874
2015-06-11 ATRS Flynn James E 24,612 2.4797 24,612 2.4797 61,030
2015-06-11 ATRS Flynn James E 28,574 2.4662 28,574 2.4662 70,469
2015-06-11 ATRS Flynn James E 74,137 2.4797 74,137 2.4797 183,838
2015-06-11 ATRS Flynn James E 58,251 2.4797 58,251 2.4797 144,445
2015-06-11 ATRS Flynn James E 86,071 2.4662 86,071 2.4662 212,268
2015-06-11 ATRS Flynn James E 67,627 2.4662 67,627 2.4662 166,782

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

AIS / Tidal Trust III - VistaShares Artificial Intelligence Supercycle ETF Insider Trades
Compras Internas EHTH / eHealth, Inc. - Análise de Lucro de Curto Prazo

Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em AIS / Tidal Trust III - VistaShares Artificial Intelligence Supercycle ETF. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Máx
Preço em
Máx
Lucro
Máx ($)
Retorno Máx (%)
2015-01-14 EHTH Flynn James E 107,280 19.8350 107,280 19.8350 2,127,899 0 20.8000 103,526 4.87
2015-01-14 EHTH Flynn James E 132,720 19.8350 132,720 19.8350 2,632,501
2015-01-14 EHTH Flynn James E 339,720 20.4500 339,720 20.4500 6,947,274
2015-01-14 EHTH Flynn James E 420,280 20.4500 420,280 20.4500 8,594,726
2014-08-07 EHTH Flynn James E 1,400 21.0500 1,400 21.0500 29,470
2014-08-07 EHTH Flynn James E 1,731 21.0500 1,731 21.0500 36,438
2014-08-05 EHTH Flynn James E 1,685 20.9900 1,685 20.9900 35,368
2014-08-05 EHTH Flynn James E 2,085 20.9900 2,085 20.9900 43,764
2014-08-04 EHTH Flynn James E 5,757 20.4000 5,757 20.4000 117,443
2014-08-04 EHTH Flynn James E 63,738 20.7500 63,738 20.7500 1,322,564
2014-08-04 EHTH Flynn James E 7,122 20.4000 7,122 20.4000 145,289
2014-08-04 EHTH Flynn James E 78,853 20.7500 78,853 20.7500 1,636,200
2014-08-01 EHTH Flynn James E 65,396 19.0400 65,396 19.0400 1,245,140
2014-08-01 EHTH Flynn James E 10,728 19.4000 10,728 19.4000 208,123
2014-08-01 EHTH Flynn James E 80,904 19.0400 80,904 19.0400 1,540,412
2014-08-01 EHTH Flynn James E 13,272 19.4000 13,272 19.4000 257,477

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

EHTH / eHealth, Inc. Insider Trades
Vendas Internas EHTH / eHealth, Inc. - Análise de Perda de Curto Prazo

Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em AIS / Tidal Trust III - VistaShares Artificial Intelligence Supercycle ETF. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Mín
Preço em
Mín
Máxima Perda
Evitada ($)
Máxima Perda
Evitada (%)
2017-04-27 EHTH Flynn James E 183,805 11.7100 183,805 11.7100 2,152,357 0 11.7400 5,515 0.26
2017-04-27 EHTH Flynn James E 58,067 11.7100 58,067 11.7100 679,965
2017-04-27 EHTH Flynn James E 71,837 11.7100 71,837 11.7100 841,211
2017-04-26 EHTH Flynn James E 66,351 11.5200 66,351 11.5200 764,364
2017-04-26 EHTH Flynn James E 20,962 11.5200 20,962 11.5200 241,482
2017-04-26 EHTH Flynn James E 25,932 11.5200 25,932 11.5200 298,737
2017-04-13 EHTH Flynn James E 87,886 11.0000 87,886 11.0000 966,746
2017-04-13 EHTH Flynn James E 27,765 11.0000 27,765 11.0000 305,415
2017-04-13 EHTH Flynn James E 34,349 11.0000 34,349 11.0000 377,839
2017-04-11 EHTH Flynn James E 19,593 11.0125 19,593 11.0125 215,768
2017-04-11 EHTH Flynn James E 6,189 11.0125 6,189 11.0125 68,156
2017-04-11 EHTH Flynn James E 7,658 11.0125 7,658 11.0125 84,334
2017-04-10 EHTH Flynn James E 46,730 11.0375 46,730 11.0375 515,782
2017-04-10 EHTH Flynn James E 14,763 11.0375 14,763 11.0375 162,947
2017-04-10 EHTH Flynn James E 18,264 11.0375 18,264 11.0375 201,589
2017-04-07 EHTH Flynn James E 69,667 11.7163 69,667 11.7163 816,239
2017-04-07 EHTH Flynn James E 22,009 11.7163 22,009 11.7163 257,864
2017-04-07 EHTH Flynn James E 27,228 11.7163 27,228 11.7163 319,011
2016-06-21 EHTH Flynn James E 26,400 14.3012 26,400 14.3012 377,552
2016-06-20 EHTH Flynn James E 178,454 14.1970 178,454 14.1970 2,533,511
2016-06-14 EHTH Flynn James E 43,300 13.8838 43,300 13.8838 601,169
2016-06-08 EHTH Flynn James E 28,080 13.8402 28,080 13.8402 388,633
2016-06-07 EHTH Flynn James E 7,154 13.8915 7,154 13.8915 99,380
2016-06-06 EHTH Flynn James E 28,502 14.0003 28,502 14.0003 399,037
2016-06-02 EHTH Flynn James E 42,668 13.8685 42,668 13.8685 591,741
2016-06-01 EHTH Flynn James E 5 13.8000 5 13.8000 69
2016-05-31 EHTH Flynn James E 56,835 13.8405 56,835 13.8405 786,625
2016-05-27 EHTH Flynn James E 72,649 13.9978 72,649 13.9978 1,016,926
2016-05-26 EHTH Flynn James E 93,965 14.1628 93,965 14.1628 1,330,808
2016-05-25 EHTH Flynn James E 45,967 14.2531 45,967 14.2531 655,172
2015-03-06 EHTH DEERFIELD MANAGEMENT CO 600,544 9.5200 600,544 9.5200 5,717,179
2015-03-06 EHTH DEERFIELD MANAGEMENT CO 742,029 9.5200 742,029 9.5200 7,064,116

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

EHTH / eHealth, Inc. Insider Trades
Compras Internas LRMR / Larimar Therapeutics, Inc. - Análise de Lucro de Curto Prazo

Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em AIS / Tidal Trust III - VistaShares Artificial Intelligence Supercycle ETF. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Máx
Preço em
Máx
Lucro
Máx ($)
Retorno Máx (%)
2016-02-12 ZFGN Flynn James E 22,296 6.2466 22,296 6.2466 139,274 6
2016-02-12 ZFGN Flynn James E 28,377 6.2466 28,377 6.2466 177,260
2016-02-12 ZFGN Flynn James E 13,872 6.2466 13,872 6.2466 86,653
2016-02-11 ZFGN Flynn James E 810 6.1884 810 6.1884 5,013
2016-02-11 ZFGN Flynn James E 1,030 6.1884 1,030 6.1884 6,374
2016-02-11 ZFGN Flynn James E 504 6.1884 504 6.1884 3,119
2016-02-10 ZFGN Flynn James E 52,239 6.2323 52,239 6.2323 325,569
2016-02-10 ZFGN Flynn James E 66,486 6.2323 66,486 6.2323 414,361
2016-02-10 ZFGN Flynn James E 32,501 6.2323 32,501 6.2323 202,556
2016-02-09 ZFGN Flynn James E 39,353 5.7291 39,353 5.7291 225,457
2016-02-09 ZFGN Flynn James E 50,086 5.7291 50,086 5.7291 286,948
2016-02-09 ZFGN Flynn James E 24,484 5.7291 24,484 5.7291 140,271

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

LRMR / Larimar Therapeutics, Inc. Insider Trades
Vendas Internas LRMR / Larimar Therapeutics, Inc. - Análise de Perda de Curto Prazo

Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em AIS / Tidal Trust III - VistaShares Artificial Intelligence Supercycle ETF. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Mín
Preço em
Mín
Máxima Perda
Evitada ($)
Máxima Perda
Evitada (%)
2016-07-20 ZFGN Flynn James E 193,630 3.3118 193,630 3.3118 641,264 8
2016-07-20 ZFGN Flynn James E 246,439 3.3118 246,439 3.3118 816,157
2016-07-20 ZFGN Flynn James E 901,430 3.3118 901,430 3.3118 2,985,356

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

LRMR / Larimar Therapeutics, Inc. Insider Trades
Compras Internas PRTO / Tidal Trust Iii - Rcn Pareto Strategic Allocation Etf - Análise de Lucro de Curto Prazo

Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em AIS / Tidal Trust III - VistaShares Artificial Intelligence Supercycle ETF. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Máx
Preço em
Máx
Lucro
Máx ($)
Retorno Máx (%)
2017-11-30 PRTO Flynn James E 110,557 1.7500 110,557 1.7500 193,475 730

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

PRTO / Tidal Trust Iii - Rcn Pareto Strategic Allocation Etf Insider Trades
Vendas Internas PRTO / Tidal Trust Iii - Rcn Pareto Strategic Allocation Etf - Análise de Perda de Curto Prazo

Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em AIS / Tidal Trust III - VistaShares Artificial Intelligence Supercycle ETF. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Mín
Preço em
Mín
Máxima Perda
Evitada ($)
Máxima Perda
Evitada (%)
2017-11-30 PRTO Flynn James E 110,557 1.7500 110,557 1.7500 193,475 730

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

PRTO / Tidal Trust Iii - Rcn Pareto Strategic Allocation Etf Insider Trades
Compras Internas RGNX / REGENXBIO Inc. - Análise de Lucro de Curto Prazo

Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em AIS / Tidal Trust III - VistaShares Artificial Intelligence Supercycle ETF. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Máx
Preço em
Máx
Lucro
Máx ($)
Retorno Máx (%)
2015-09-22 RGNX Flynn James E 87,500 22.0000 87,500 22.0000 1,925,000 2 26.43 387,625 20.14
2015-09-22 RGNX Flynn James E 38,500 22.0000 38,500 22.0000 847,000
2015-09-22 RGNX Flynn James E 49,000 22.0000 49,000 22.0000 1,078,000

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

RGNX / REGENXBIO Inc. Insider Trades
Vendas Internas RGNX / REGENXBIO Inc. - Análise de Perda de Curto Prazo

Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em AIS / Tidal Trust III - VistaShares Artificial Intelligence Supercycle ETF. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Mín
Preço em
Mín
Máxima Perda
Evitada ($)
Máxima Perda
Evitada (%)
Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

RGNX / REGENXBIO Inc. Insider Trades
Compras Internas VNDA / Vanda Pharmaceuticals Inc. - Análise de Lucro de Curto Prazo

Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em AIS / Tidal Trust III - VistaShares Artificial Intelligence Supercycle ETF. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Máx
Preço em
Máx
Lucro
Máx ($)
Retorno Máx (%)
2015-12-11 VNDA Flynn James E 100,864 8.6089 100,864 8.6089 868,328 304 17.6300 909,904 104.79
2015-12-11 VNDA Flynn James E 128,374 8.6089 128,374 8.6089 1,105,159
2015-12-11 VNDA Flynn James E 93,634 8.6089 93,634 8.6089 806,086
2015-12-11 VNDA Flynn James E 100,864 8.6089 100,864 8.6089 868,328
2015-12-11 VNDA Flynn James E 128,374 8.6089 128,374 8.6089 1,105,159
2015-12-10 VNDA Flynn James E 40,997 8.5902 40,997 8.5902 352,172
2015-12-10 VNDA Flynn James E 32,211 8.5902 32,211 8.5902 276,699
2015-12-10 VNDA Flynn James E 29,902 8.5902 29,902 8.5902 256,864
2015-12-10 VNDA Flynn James E 32,211 8.5902 32,211 8.5902 276,699
2015-12-10 VNDA Flynn James E 40,997 8.5902 40,997 8.5902 352,172
2015-12-09 VNDA Flynn James E 229,833 8.2110 229,833 8.2110 1,887,159
2015-12-09 VNDA Flynn James E 292,515 8.2110 292,515 8.2110 2,401,841
2015-12-09 VNDA Flynn James E 213,358 8.2110 213,358 8.2110 1,751,883
2015-12-09 VNDA Flynn James E 12,395 9.0000 12,395 9.0000 111,555
2015-12-09 VNDA Flynn James E 15,775 9.0000 15,775 9.0000 141,975
2015-12-09 VNDA Flynn James E 11,506 9.0000 11,506 9.0000 103,554
2014-12-23 VNDA Flynn James E 11,100 14.2300 11,100 14.2300 157,953
2014-12-23 VNDA Flynn James E 13,900 14.2300 13,900 14.2300 197,797
2014-12-23 VNDA Flynn James E 13,320 14.4800 13,320 14.4800 192,874
2014-12-23 VNDA Flynn James E 16,680 14.4800 16,680 14.4800 241,526
2014-12-23 VNDA Flynn James E 11,100 14.5000 11,100 14.5000 160,950
2014-12-23 VNDA Flynn James E 13,900 14.5000 13,900 14.5000 201,550
2014-12-23 VNDA Flynn James E 8,880 14.3300 8,880 14.3300 127,250
2014-12-23 VNDA Flynn James E 11,120 14.3300 11,120 14.3300 159,350
2014-12-23 VNDA Flynn James E 11,100 14.3000 11,100 14.3000 158,730
2014-12-23 VNDA Flynn James E 13,900 14.3000 13,900 14.3000 198,770
2014-12-23 VNDA Flynn James E 16,434 14.4800 16,434 14.4800 237,964
2014-12-23 VNDA Flynn James E 20,580 14.4800 20,580 14.4800 297,998

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

VNDA / Vanda Pharmaceuticals Inc. Insider Trades
Vendas Internas VNDA / Vanda Pharmaceuticals Inc. - Análise de Perda de Curto Prazo

Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em AIS / Tidal Trust III - VistaShares Artificial Intelligence Supercycle ETF. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Mín
Preço em
Mín
Máxima Perda
Evitada ($)
Máxima Perda
Evitada (%)
2016-09-23 VNDA Flynn James E 273,632 16.7070 273,632 16.7070 4,571,570 122 13.0500 -1,000,671 -21.89
2016-09-23 VNDA Flynn James E 348,258 16.7070 348,258 16.7070 5,818,346
2016-09-23 VNDA Flynn James E 157,607 16.7070 157,607 16.7070 2,633,140
2016-09-22 VNDA Flynn James E 119,690 16.2390 119,690 16.2390 1,943,646
2016-09-22 VNDA Flynn James E 152,334 16.2390 152,334 16.2390 2,473,752
2016-09-22 VNDA Flynn James E 68,940 16.2390 68,940 16.2390 1,119,517
2016-09-19 VNDA Flynn James E 3,857 15.5280 3,857 15.5280 59,891
2016-09-19 VNDA Flynn James E 4,910 15.5280 4,910 15.5280 76,242
2016-09-19 VNDA Flynn James E 37,044 15.5800 37,044 15.5800 577,146
2016-09-16 VNDA Flynn James E 93,506 15.6190 93,506 15.6190 1,460,470
2016-09-16 VNDA Flynn James E 119,008 15.6190 119,008 15.6190 1,858,786
2016-09-16 VNDA Flynn James E 87,858 15.6190 87,858 15.6190 1,372,254
2016-09-15 VNDA Flynn James E 62,791 15.7550 62,791 15.7550 989,272
2016-09-15 VNDA Flynn James E 79,915 15.7550 79,915 15.7550 1,259,061
2016-09-15 VNDA Flynn James E 58,997 15.7550 58,997 15.7550 929,498

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

VNDA / Vanda Pharmaceuticals Inc. Insider Trades
Histórico de Negociações Insider

Esta tabela mostra a lista completa de negociações insider realizadas por Deerfield International Master Fund, L.P. conforme divulgadas para a Comissão de Valores Mobiliários (SEC).

Data do Arquivo Data da Transação Formulário Ticker Ativo Código 10b5-1 Ações Ações Restantes Variação
Percentual
Preço
da Ação
Valor
da Transação
Valor
Restante
2017-12-04 2017-11-30 4 PRTO PROTEON THERAPEUTICS INC
Common Stock
S - Sale -110,557 0 -100.00 1.75 -193,475
2017-12-04 2017-11-30 4 PRTO PROTEON THERAPEUTICS INC
Common Stock
P - Purchase 110,557 197,424 127.27 1.75 193,475 345,492
2017-08-04 3 PRTO PROTEON THERAPEUTICS INC
Common Stock
2,102,698
2017-08-04 3 PRTO PROTEON THERAPEUTICS INC
Common Stock
1,374,575
2017-08-04 3 PRTO PROTEON THERAPEUTICS INC
Common Stock
1,335,456
2017-08-04 3 PRTO PROTEON THERAPEUTICS INC
Common Stock
1,311,766
2017-08-04 3 PRTO PROTEON THERAPEUTICS INC
Common Stock
2,102,698
2017-08-04 3 PRTO PROTEON THERAPEUTICS INC
Common Stock
1,374,575
2017-08-04 3 PRTO PROTEON THERAPEUTICS INC
Common Stock
1,335,456
2017-08-04 3 PRTO PROTEON THERAPEUTICS INC
Common Stock
1,311,766
2017-08-04 3 PRTO PROTEON THERAPEUTICS INC
Common Stock
2,102,698
2017-08-04 3 PRTO PROTEON THERAPEUTICS INC
Common Stock
1,374,575
2017-08-04 3 PRTO PROTEON THERAPEUTICS INC
Common Stock
1,335,456
2017-08-04 3 PRTO PROTEON THERAPEUTICS INC
Common Stock
1,311,766
2017-08-04 3 PRTO PROTEON THERAPEUTICS INC
Common Stock
2,102,698
2017-08-04 3 PRTO PROTEON THERAPEUTICS INC
Common Stock
1,374,575
2017-08-04 3 PRTO PROTEON THERAPEUTICS INC
Common Stock
1,335,456
2017-08-04 3 PRTO PROTEON THERAPEUTICS INC
Common Stock
1,311,766
2017-08-04 3 PRTO PROTEON THERAPEUTICS INC
Common Stock
2,102,698
2017-08-04 3 PRTO PROTEON THERAPEUTICS INC
Common Stock
1,374,575
2017-08-04 3 PRTO PROTEON THERAPEUTICS INC
Common Stock
1,335,456
2017-08-04 3 PRTO PROTEON THERAPEUTICS INC
Common Stock
1,311,766
2017-08-04 3 PRTO PROTEON THERAPEUTICS INC
Common Stock
2,102,698
2017-08-04 3 PRTO PROTEON THERAPEUTICS INC
Common Stock
1,374,575
2017-08-04 3 PRTO PROTEON THERAPEUTICS INC
Common Stock
1,335,456
2017-08-04 3 PRTO PROTEON THERAPEUTICS INC
Common Stock
1,311,766
2017-08-04 3 PRTO PROTEON THERAPEUTICS INC
Common Stock
2,102,698
2017-08-04 3 PRTO PROTEON THERAPEUTICS INC
Common Stock
1,374,575
2017-08-04 3 PRTO PROTEON THERAPEUTICS INC
Common Stock
1,335,456
2017-08-04 3 PRTO PROTEON THERAPEUTICS INC
Common Stock
1,311,766
2017-08-04 3 PRTO PROTEON THERAPEUTICS INC
Common Stock
2,102,698
2017-08-04 3 PRTO PROTEON THERAPEUTICS INC
Common Stock
1,374,575
2017-08-04 3 PRTO PROTEON THERAPEUTICS INC
Common Stock
1,335,456
2017-08-04 3 PRTO PROTEON THERAPEUTICS INC
Common Stock
1,311,766
2017-08-04 3 PRTO PROTEON THERAPEUTICS INC
Common Stock
2,102,698
2017-08-04 3 PRTO PROTEON THERAPEUTICS INC
Common Stock
1,374,575
2017-08-04 3 PRTO PROTEON THERAPEUTICS INC
Common Stock
1,335,456
2017-08-04 3 PRTO PROTEON THERAPEUTICS INC
Common Stock
1,311,766
2017-08-04 3 PRTO PROTEON THERAPEUTICS INC
Common Stock
2,102,698
2017-08-04 3 PRTO PROTEON THERAPEUTICS INC
Common Stock
1,374,575
2017-08-04 3 PRTO PROTEON THERAPEUTICS INC
Common Stock
1,335,456
2017-08-04 3 PRTO PROTEON THERAPEUTICS INC
Common Stock
1,311,766
2017-08-04 3 PRTO PROTEON THERAPEUTICS INC
Common Stock
2,102,698
2017-08-04 3 PRTO PROTEON THERAPEUTICS INC
Common Stock
1,374,575
2017-08-04 3 PRTO PROTEON THERAPEUTICS INC
Common Stock
1,335,456
2017-08-04 3 PRTO PROTEON THERAPEUTICS INC
Common Stock
1,311,766
2017-06-14 2017-06-14 4 REPH Recro Pharma, Inc.
Common Stock
S - Sale -68,000 1,176,685 -5.46 6.25 -425,000 7,354,281
2017-06-14 2017-06-13 4 REPH Recro Pharma, Inc.
Common Stock
S - Sale -32,447 1,244,685 -2.54 6.59 -213,826 8,202,474
2017-06-14 2017-06-12 4 REPH Recro Pharma, Inc.
Common Stock
S - Sale -10,000 1,277,132 -0.78 6.74 -67,400 8,607,870
2017-06-09 2017-06-08 4 REPH Recro Pharma, Inc.
Common Stock
S - Sale -17,245 1,287,132 -1.32 6.99 -120,543 8,997,053
2017-06-09 2017-06-07 4 REPH Recro Pharma, Inc.
Common Stock
S - Sale -45,623 1,304,377 -3.38 7.09 -323,467 9,248,033
2017-04-27 2017-04-27 4 EHTH eHealth, Inc.
Common Stock
S - Sale -71,837 877,606 -7.57 11.71 -841,211 10,276,766
2017-04-27 2017-04-27 4 EHTH eHealth, Inc.
Common Stock
S - Sale -58,067 709,386 -7.57 11.71 -679,965 8,306,910
2017-04-27 2017-04-27 4 EHTH eHealth, Inc.
Common Stock
S - Sale -183,805 244,562 -42.91 11.71 -2,152,357 2,863,821
2017-04-27 2017-04-26 4 EHTH eHealth, Inc.
Common Stock
S - Sale -25,932 949,443 -2.66 11.52 -298,737 10,937,583
2017-04-27 2017-04-26 4 EHTH eHealth, Inc.
Common Stock
S - Sale -20,962 767,453 -2.66 11.52 -241,482 8,841,059
2017-04-27 2017-04-26 4 EHTH eHealth, Inc.
Common Stock
S - Sale -66,351 428,367 -13.41 11.52 -764,364 4,934,788
2017-04-17 2017-04-13 4 EHTH eHealth, Inc.
Common Stock
S - Sale -34,349 975,375 -3.40 11.00 -377,839 10,729,125
2017-04-17 2017-04-13 4 EHTH eHealth, Inc.
Common Stock
S - Sale -27,765 788,415 -3.40 11.00 -305,415 8,672,565
2017-04-17 2017-04-13 4 EHTH eHealth, Inc.
Common Stock
S - Sale -87,886 494,718 -15.09 11.00 -966,746 5,441,898
2017-04-11 2017-04-11 4 EHTH eHealth, Inc.
Common Stock
S - Sale -7,658 1,009,724 -0.75 11.01 -84,334 11,119,586
2017-04-11 2017-04-11 4 EHTH eHealth, Inc.
Common Stock
S - Sale -6,189 816,180 -0.75 11.01 -68,156 8,988,182
2017-04-11 2017-04-11 4 EHTH eHealth, Inc.
Common Stock
S - Sale -19,593 582,604 -3.25 11.01 -215,768 6,415,927
2017-04-11 2017-04-10 4 EHTH eHealth, Inc.
Common Stock
S - Sale -18,264 1,017,382 -1.76 11.04 -201,589 11,229,354
2017-04-11 2017-04-10 4 EHTH eHealth, Inc.
Common Stock
S - Sale -14,763 822,369 -1.76 11.04 -162,947 9,076,898
2017-04-11 2017-04-10 4 EHTH eHealth, Inc.
Common Stock
S - Sale -46,730 602,197 -7.20 11.04 -515,782 6,646,749
2017-04-11 2017-04-07 4 EHTH eHealth, Inc.
Common Stock
S - Sale -27,228 1,035,646 -2.56 11.72 -319,011 12,133,939
2017-04-11 2017-04-07 4 EHTH eHealth, Inc.
Common Stock
S - Sale -22,009 837,132 -2.56 11.72 -257,864 9,808,090
2017-04-11 2017-04-07 4 EHTH eHealth, Inc.
Common Stock
S - Sale -69,667 648,927 -9.69 11.72 -816,239 7,603,023
2016-12-16 3 REPH Recro Pharma, Inc.
Common stock
2,392,550
2016-12-16 3 REPH Recro Pharma, Inc.
Common stock
2,482,450
2016-12-16 3 REPH Recro Pharma, Inc.
Common stock
3,425,000
2016-12-16 3 REPH Recro Pharma, Inc.
Common stock
2,392,550
2016-12-16 3 REPH Recro Pharma, Inc.
Common stock
2,482,450
2016-12-16 3 REPH Recro Pharma, Inc.
Common stock
3,425,000
2016-12-16 3 REPH Recro Pharma, Inc.
Common stock
2,392,550
2016-12-16 3 REPH Recro Pharma, Inc.
Common stock
2,482,450
2016-12-16 3 REPH Recro Pharma, Inc.
Common stock
3,425,000
2016-12-16 3 REPH Recro Pharma, Inc.
Common stock
2,392,550
2016-12-16 3 REPH Recro Pharma, Inc.
Common stock
2,482,450
2016-12-16 3 REPH Recro Pharma, Inc.
Common stock
3,425,000
2016-12-16 3 REPH Recro Pharma, Inc.
Common stock
2,392,550
2016-12-16 3 REPH Recro Pharma, Inc.
Common stock
2,482,450
2016-12-16 3 REPH Recro Pharma, Inc.
Common stock
3,425,000
2016-12-16 3 REPH Recro Pharma, Inc.
Common stock
2,392,550
2016-12-16 3 REPH Recro Pharma, Inc.
Common stock
2,482,450
2016-12-16 3 REPH Recro Pharma, Inc.
Common stock
3,425,000
2016-12-16 3 REPH Recro Pharma, Inc.
Common stock
2,392,550
2016-12-16 3 REPH Recro Pharma, Inc.
Common stock
2,482,450
2016-12-16 3 REPH Recro Pharma, Inc.
Common stock
3,425,000
2016-09-26 2016-09-23 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -157,607 693,171 -18.53 16.71 -2,633,140 11,580,808
2016-09-26 2016-09-23 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -348,258 2,035,697 -14.61 16.71 -5,818,346 34,010,390
2016-09-26 2016-09-23 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -273,632 1,599,476 -14.61 16.71 -4,571,570 26,722,446
2016-09-26 2016-09-22 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -68,940 850,778 -7.50 16.24 -1,119,517 13,815,784
2016-09-26 2016-09-22 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -152,334 2,383,955 -6.01 16.24 -2,473,752 38,713,045
2016-09-26 2016-09-22 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -119,690 1,873,108 -6.01 16.24 -1,943,646 30,417,401
2016-09-19 2016-09-19 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -37,044 919,718 -3.87 15.58 -577,146 14,329,206
2016-09-19 2016-09-19 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -4,910 2,536,289 -0.19 15.53 -76,242 39,383,496
2016-09-19 2016-09-19 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -3,857 1,992,798 -0.19 15.53 -59,891 30,944,167
2016-09-19 2016-09-16 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -87,858 956,762 -8.41 15.62 -1,372,254 14,943,666
2016-09-19 2016-09-16 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -119,008 2,541,199 -4.47 15.62 -1,858,786 39,690,987
2016-09-19 2016-09-16 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -93,506 1,996,655 -4.47 15.62 -1,460,470 31,185,754
2016-09-19 2016-09-15 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -58,997 1,044,620 -5.35 15.76 -929,498 16,457,988
2016-09-19 2016-09-15 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -79,915 2,660,207 -2.92 15.76 -1,259,061 41,911,561
2016-09-19 2016-09-15 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
S - Sale -62,791 2,090,161 -2.92 15.76 -989,272 32,930,487
2016-08-01 2016-07-20 4 ZFGN ZAFGEN, INC.
Common Stock
S - Sale -901,430 1,151,802 -43.90 3.31 -2,985,356 3,814,538
2016-08-01 2016-07-20 4 ZFGN ZAFGEN, INC.
Common Stock
S - Sale -246,439 314,889 -43.90 3.31 -816,157 1,042,849
2016-08-01 2016-07-20 4 ZFGN ZAFGEN, INC.
Common Stock
S - Sale -193,630 247,413 -43.90 3.31 -641,264 819,382
2016-06-22 2016-06-21 4 EHTH eHealth, Inc.
Common Stock
S - Sale -26,400 718,594 -3.54 14.30 -377,552 10,276,757
2016-06-22 2016-06-20 4 EHTH eHealth, Inc.
Common Stock
S - Sale -178,454 744,994 -19.32 14.20 -2,533,511 10,576,680
2016-06-16 2016-06-14 4 EHTH eHealth, Inc.
Common Stock
S - Sale -43,300 923,448 -4.48 13.88 -601,169 12,820,967
2016-06-08 2016-06-08 4 EHTH eHealth, Inc.
Common Stock
S - Sale -28,080 966,748 -2.82 13.84 -388,633 13,379,986
2016-06-08 2016-06-07 4 EHTH eHealth, Inc.
Common Stock
S - Sale -7,154 994,828 -0.71 13.89 -99,380 13,819,653
2016-06-08 2016-06-06 4 EHTH eHealth, Inc.
Common Stock
S - Sale -28,502 1,001,982 -2.77 14.00 -399,037 14,028,049
2016-06-02 2016-06-02 4 EHTH eHealth, Inc.
Common Stock
S - Sale -42,668 1,030,484 -3.98 13.87 -591,741 14,291,267
2016-06-02 2016-06-01 4 EHTH eHealth, Inc.
Common Stock
S - Sale -5 1,073,152 0.00 13.80 -69 14,809,498
2016-06-02 2016-05-31 4 EHTH eHealth, Inc.
Common Stock
S - Sale -56,835 1,073,157 -5.03 13.84 -786,625 14,853,029
2016-05-27 2016-05-27 4 EHTH eHealth, Inc.
Common Stock
S - Sale -72,649 1,129,992 -6.04 14.00 -1,016,926 15,817,402
2016-05-27 2016-05-26 4 EHTH eHealth, Inc.
Common Stock
S - Sale -93,965 1,202,641 -7.25 14.16 -1,330,808 17,032,764
2016-05-27 2016-05-25 4 EHTH eHealth, Inc.
Common Stock
S - Sale -45,967 1,296,606 -3.42 14.25 -655,172 18,480,655
2016-02-23 2016-02-19 4 XNPT XENOPORT INC
Common Stock
P - Purchase 11,745 2,746,650 0.43 3.99 46,843 10,954,464
2016-02-23 2016-02-19 4 XNPT XENOPORT INC
Common Stock
P - Purchase 9,228 2,158,084 0.43 3.99 36,804 8,607,086
2016-02-19 2016-02-17 4 AVXS AveXis, Inc.
Class D Preferred Stock
C - Conversion -117,998 0 -100.00
2016-02-19 2016-02-17 4 AVXS AveXis, Inc.
Class D Preferred Stock
C - Conversion -117,996 0 -100.00
2016-02-19 2016-02-17 4 AVXS AveXis, Inc.
Class C Preferred Stock
C - Conversion -1,182,941 0 -100.00
2016-02-19 2016-02-17 4 AVXS AveXis, Inc.
Class B-1 Preferred Stock
C - Conversion -67,448 0 -100.00
2016-02-19 2016-02-17 4 AVXS AveXis, Inc.
Common Stock
P - Purchase 112,000 112,000 20.00 2,240,000 2,240,000
2016-02-19 2016-02-17 4 AVXS AveXis, Inc.
Common Stock
P - Purchase 88,000 88,000 20.00 1,760,000 1,760,000
2016-02-19 2016-02-17 4 AVXS AveXis, Inc.
Common Stock
P - Purchase 163,702 413,611 65.50 20.00 3,274,040 8,272,220
2016-02-19 2016-02-17 4 AVXS AveXis, Inc.
Common Stock
P - Purchase 122,793 1,623,089 8.18 20.00 2,455,860 32,461,780
2016-02-19 2016-02-17 4 AVXS AveXis, Inc.
Common Stock
C - Conversion 117,998 249,909 89.45
2016-02-19 2016-02-17 4 AVXS AveXis, Inc.
Common Stock
C - Conversion 117,996 1,500,296 8.54
2016-02-19 2016-02-17 4 AVXS AveXis, Inc.
Common Stock
C - Conversion 1,182,941 1,382,300 593.37
2016-02-19 2016-02-17 4 AVXS AveXis, Inc.
Common Stock
C - Conversion 67,448 199,359 51.13
2016-02-19 2015-09-03 4 AVXS AveXis, Inc.
Class D Preferred Stock
P - Purchase 117,998 0 -100.00 21.01 2,479,138
2016-02-19 2015-09-03 4 AVXS AveXis, Inc.
Class D Preferred Stock
P - Purchase 117,996 0 -100.00 21.01 2,479,096
2016-02-19 2015-09-03 4 AVXS AveXis, Inc.
Common Stock
P - Purchase 131,911 131,911 18.48 2,437,715 2,437,715
2016-02-19 2015-09-03 4 AVXS AveXis, Inc.
Common Stock
P - Purchase 131,911 131,911 18.48 2,437,715 2,437,715
2016-02-19 3 AVXS AveXis, Inc.
Common Stock
298,000
2016-02-19 3 AVXS AveXis, Inc.
Common Stock
332,000
2016-02-19 3 AVXS AveXis, Inc.
Common Stock
298,000
2016-02-19 3 AVXS AveXis, Inc.
Common Stock
332,000
2016-02-19 3 AVXS AveXis, Inc.
Common Stock
298,000
2016-02-19 3 AVXS AveXis, Inc.
Common Stock
332,000
2016-02-17 2016-02-12 4 ZFGN ZAFGEN, INC.
Common Stock
P - Purchase 13,872 2,053,232 0.68 6.25 86,653 12,825,719
2016-02-17 2016-02-12 4 ZFGN ZAFGEN, INC.
Common Stock
P - Purchase 28,377 561,328 5.32 6.25 177,260 3,506,391
2016-02-17 2016-02-12 4 ZFGN ZAFGEN, INC.
Common Stock
P - Purchase 22,296 441,043 5.32 6.25 139,274 2,755,019
2016-02-16 2016-02-12 4 XNPT XENOPORT INC
Common Stock
P - Purchase 19,725 2,734,905 0.73 3.92 77,381 10,729,032
2016-02-16 2016-02-12 4 XNPT XENOPORT INC
Common Stock
P - Purchase 15,499 2,148,856 0.73 3.92 60,803 8,429,962
2016-02-16 2016-02-11 4 XNPT XENOPORT INC
Common Stock
P - Purchase 1,157,189 2,715,180 74.27 3.76 4,349,642 10,205,819
2016-02-16 2016-02-11 4 XNPT XENOPORT INC
Common Stock
P - Purchase 909,221 2,133,357 74.27 3.76 3,417,580 8,018,862
2016-02-16 2016-02-11 4 XNPT XENOPORT INC
Common Stock
P - Purchase 1,557,991 1,557,991 3.96 6,166,840 6,166,840
2016-02-16 2016-02-11 4 XNPT XENOPORT INC
Common Stock
P - Purchase 1,224,136 1,224,136 3.96 4,845,375 4,845,375
2016-02-16 3 XNPT XENOPORT INC
Common Stock
108,000
2016-02-16 3 XNPT XENOPORT INC
Common Stock
117,000
2016-02-16 3 XNPT XENOPORT INC
Common Stock
108,000
2016-02-16 3 XNPT XENOPORT INC
Common Stock
117,000
2016-02-16 3 XNPT XENOPORT INC
Common Stock
108,000
2016-02-16 3 XNPT XENOPORT INC
Common Stock
117,000
2016-02-11 2016-02-11 4 ZFGN ZAFGEN, INC.
Common Stock
P - Purchase 504 2,039,360 0.02 6.19 3,119 12,620,375
2016-02-11 2016-02-11 4 ZFGN ZAFGEN, INC.
Common Stock
P - Purchase 1,030 532,951 0.19 6.19 6,374 3,298,114
2016-02-11 2016-02-11 4 ZFGN ZAFGEN, INC.
Common Stock
P - Purchase 810 418,747 0.19 6.19 5,013 2,591,374
2016-02-11 2016-02-10 4 ZFGN ZAFGEN, INC.
Common Stock
P - Purchase 32,501 2,038,856 1.62 6.23 202,556 12,706,762
2016-02-11 2016-02-10 4 ZFGN ZAFGEN, INC.
Common Stock
P - Purchase 66,486 531,921 14.28 6.23 414,361 3,315,091
2016-02-11 2016-02-10 4 ZFGN ZAFGEN, INC.
Common Stock
P - Purchase 52,239 417,937 14.28 6.23 325,569 2,604,709
2016-02-11 2016-02-09 4 ZFGN ZAFGEN, INC.
Common Stock
P - Purchase 24,484 2,006,355 1.24 5.73 140,271 11,494,608
2016-02-11 2016-02-09 4 ZFGN ZAFGEN, INC.
Common Stock
P - Purchase 50,086 465,435 12.06 5.73 286,948 2,666,524
2016-02-11 2016-02-09 4 ZFGN ZAFGEN, INC.
Common Stock
P - Purchase 39,353 365,698 12.06 5.73 225,457 2,095,120
2016-02-11 3 ZFGN ZAFGEN, INC.
Common Stock
4,705,436
2016-02-11 3 ZFGN ZAFGEN, INC.
Common Stock
3,049,910
2016-02-11 3 ZFGN ZAFGEN, INC.
Common Stock
3,138,914
2016-02-11 3 ZFGN ZAFGEN, INC.
Common Stock
4,705,436
2016-02-11 3 ZFGN ZAFGEN, INC.
Common Stock
3,049,910
2016-02-11 3 ZFGN ZAFGEN, INC.
Common Stock
3,138,914
2016-02-11 3 ZFGN ZAFGEN, INC.
Common Stock
4,705,436
2016-02-11 3 ZFGN ZAFGEN, INC.
Common Stock
3,049,910
2016-02-11 3 ZFGN ZAFGEN, INC.
Common Stock
3,138,914
2016-02-11 3 ZFGN ZAFGEN, INC.
Common Stock
4,705,436
2016-02-11 3 ZFGN ZAFGEN, INC.
Common Stock
3,049,910
2016-02-11 3 ZFGN ZAFGEN, INC.
Common Stock
3,138,914
2016-02-11 3 ZFGN ZAFGEN, INC.
Common Stock
4,705,436
2016-02-11 3 ZFGN ZAFGEN, INC.
Common Stock
3,049,910
2016-02-11 3 ZFGN ZAFGEN, INC.
Common Stock
3,138,914
2016-02-11 3 ZFGN ZAFGEN, INC.
Common Stock
4,705,436
2016-02-11 3 ZFGN ZAFGEN, INC.
Common Stock
3,049,910
2016-02-11 3 ZFGN ZAFGEN, INC.
Common Stock
3,138,914
2016-02-11 3 ZFGN ZAFGEN, INC.
Common Stock
4,705,436
2016-02-11 3 ZFGN ZAFGEN, INC.
Common Stock
3,049,910
2016-02-11 3 ZFGN ZAFGEN, INC.
Common Stock
3,138,914
2015-12-18 2015-12-16 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
P - Purchase 3,239 1,103,617 0.29 8.97 29,042 9,895,582
2015-12-18 2015-12-16 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
P - Purchase 4,441 2,740,122 0.16 8.97 39,820 24,569,304
2015-12-18 2015-12-16 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
P - Purchase 3,490 2,152,952 0.16 8.97 31,293 19,304,444
2015-12-18 2015-12-11 4/A VNDA Vanda Pharmaceuticals Inc.
Common Stock
P - Purchase 93,634 1,100,378 9.30 8.61 806,086 9,473,044
2015-12-18 2015-12-11 4/A VNDA Vanda Pharmaceuticals Inc.
Common Stock
P - Purchase 128,374 2,735,681 4.92 8.61 1,105,159 23,551,204
2015-12-18 2015-12-11 4/A VNDA Vanda Pharmaceuticals Inc.
Common Stock
P - Purchase 100,864 2,149,462 4.92 8.61 868,328 18,504,503
2015-12-18 2015-12-10 4/A VNDA Vanda Pharmaceuticals Inc.
Common Stock
P - Purchase 29,902 1,006,744 3.06 8.59 256,864 8,648,132
2015-12-18 2015-12-10 4/A VNDA Vanda Pharmaceuticals Inc.
Common Stock
P - Purchase 40,997 2,607,307 1.60 8.59 352,172 22,397,289
2015-12-18 2015-12-10 4/A VNDA Vanda Pharmaceuticals Inc.
Common Stock
P - Purchase 32,211 2,048,598 1.60 8.59 276,699 17,597,867
2015-12-11 2015-12-11 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
P - Purchase 93,634 1,100,378 9.30 8.61 806,086 9,473,044
2015-12-11 2015-12-11 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
P - Purchase 128,374 2,726,895 4.94 8.61 1,105,159 23,475,566
2015-12-11 2015-12-11 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
P - Purchase 100,864 2,158,248 4.90 8.61 868,328 18,580,141
2015-12-11 2015-12-10 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
P - Purchase 29,902 1,006,744 3.06 8.59 256,864 8,648,132
2015-12-11 2015-12-10 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
P - Purchase 32,211 2,598,521 1.26 8.59 276,699 22,321,815
2015-12-11 2015-12-10 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
P - Purchase 40,997 2,057,384 2.03 8.59 352,172 17,673,340
2015-12-11 2015-12-09 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
P - Purchase 11,506 976,842 1.19 9.00 103,554 8,791,578
2015-12-11 2015-12-09 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
P - Purchase 15,775 2,566,310 0.62 9.00 141,975 23,096,790
2015-12-11 2015-12-09 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
P - Purchase 12,395 2,016,387 0.62 9.00 111,555 18,147,483
2015-12-11 2015-12-09 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
P - Purchase 213,358 965,336 28.37 8.21 1,751,883 7,926,374
2015-12-11 2015-12-09 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
P - Purchase 292,515 2,550,535 12.95 8.21 2,401,841 20,942,443
2015-12-11 2015-12-09 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
P - Purchase 229,833 2,003,992 12.95 8.21 1,887,159 16,454,778
2015-09-30 2015-09-30 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -83,930 5,348,776 -1.54 1.69 -142,018 9,050,664
2015-09-30 2015-09-30 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -106,820 6,807,533 -1.54 1.69 -180,750 11,519,027
2015-09-30 2015-09-30 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -59,248 3,294,817 -1.77 1.69 -100,254 5,575,160
2015-09-30 2015-09-29 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -34,450 5,432,706 -0.63 1.83 -63,044 9,941,852
2015-09-30 2015-09-29 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -43,845 6,914,353 -0.63 1.83 -80,236 12,653,266
2015-09-30 2015-09-29 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -11,081 3,354,065 -0.33 1.82 -20,176 6,107,082
2015-09-30 2015-09-29 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -15,696 5,467,156 -0.29 1.82 -28,579 9,954,598
2015-09-30 2015-09-29 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -19,976 6,958,198 -0.29 1.82 -36,372 12,669,487
2015-09-30 2015-09-29 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -23,700 3,365,146 -0.70 1.81 -42,897 6,090,914
2015-09-30 2015-09-29 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -33,572 5,482,852 -0.61 1.81 -60,765 9,923,962
2015-09-30 2015-09-29 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -42,728 6,978,174 -0.61 1.81 -77,338 12,630,495
2015-09-30 2015-09-28 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -368,676 5,516,424 -6.26 1.81 -669,036 10,010,655
2015-09-30 2015-09-28 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -469,224 7,020,902 -6.26 1.81 -851,501 12,740,831
2015-09-30 2015-09-28 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -226,857 5,885,100 -3.71 1.80 -408,774 10,604,362
2015-09-30 2015-09-28 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -288,726 7,490,126 -3.71 1.80 -520,255 13,496,458
2015-09-22 2015-09-22 4 RGNX REGENXBIO Inc.
Series D Convertible Preferred Stock
C - Conversion -397,079 0 -100.00
2015-09-22 2015-09-22 4 RGNX REGENXBIO Inc.
Series C Convertible Preferred Stock
C - Conversion -771,963 0 -100.00
2015-09-22 2015-09-22 4 RGNX REGENXBIO Inc.
Common Stock
P - Purchase 49,000 49,000 22.00 1,078,000 1,078,000
2015-09-22 2015-09-22 4 RGNX REGENXBIO Inc.
Common Stock
P - Purchase 38,500 38,500 22.00 847,000 847,000
2015-09-22 2015-09-22 4 RGNX REGENXBIO Inc.
Common Stock
P - Purchase 87,500 1,256,542 7.48 22.00 1,925,000 27,643,924
2015-09-22 2015-09-22 4 RGNX REGENXBIO Inc.
Common Stock
C - Conversion 397,079 1,169,042 51.44
2015-09-22 2015-09-22 4 RGNX REGENXBIO Inc.
Common Stock
C - Conversion 771,963 771,963
2015-07-21 2015-07-20 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -31,261 6,111,957 -0.51 2.14 -66,995 13,098,535
2015-07-21 2015-07-20 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -39,787 7,778,852 -0.51 2.14 -85,268 16,670,858
2015-07-21 2015-07-20 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -4,048 6,143,218 -0.07 2.13 -8,622 13,085,054
2015-07-21 2015-07-20 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -5,152 7,818,639 -0.07 2.13 -10,974 16,653,701
2015-07-21 2015-07-20 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -3,245 6,147,266 -0.05 2.12 -6,879 13,032,204
2015-07-21 2015-07-20 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -4,131 7,823,791 -0.05 2.12 -8,758 16,586,437
2015-07-21 2015-07-20 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -8,096 6,150,511 -0.13 2.11 -17,083 12,977,578
2015-07-21 2015-07-20 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -10,304 7,827,922 -0.13 2.11 -21,741 16,516,915
2015-07-21 2015-07-17 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -55,338 6,158,607 -0.89 2.20 -121,921 13,568,643
2015-07-21 2015-07-17 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -70,431 7,838,226 -0.89 2.20 -155,174 17,269,180
2015-07-08 2015-07-08 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -19,598 6,213,945 -0.31 2.07 -40,501 12,841,739
2015-07-08 2015-07-08 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -24,943 7,908,657 -0.31 2.07 -51,547 16,344,031
2015-07-08 2015-07-08 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -43,956 6,233,543 -0.70 2.06 -90,330 12,809,931
2015-07-08 2015-07-08 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -55,944 7,933,600 -0.70 2.06 -114,965 16,303,548
2015-07-08 2015-07-08 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -43,956 6,277,499 -0.70 2.04 -89,890 12,837,485
2015-07-08 2015-07-08 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -55,944 7,989,544 -0.70 2.04 -114,405 16,338,617
2015-07-08 2015-07-08 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -44,000 6,321,455 -0.69 2.06 -90,420 12,990,590
2015-07-08 2015-07-08 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -56,000 8,045,488 -0.69 2.06 -115,080 16,533,478
2015-07-08 2015-07-08 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -44,000 6,365,455 -0.69 2.04 -89,980 13,017,355
2015-07-08 2015-07-08 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -56,000 8,101,488 -0.69 2.04 -114,520 16,567,543
2015-07-08 2015-07-07 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -41,650 6,409,455 -0.65 2.10 -87,369 13,445,114
2015-07-08 2015-07-07 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -53,009 8,157,488 -0.65 2.10 -111,197 17,111,963
2015-07-08 2015-07-07 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -24,108 6,451,105 -0.37 2.09 -50,395 13,485,390
2015-07-08 2015-07-07 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -30,684 8,210,497 -0.37 2.09 -64,142 17,163,223
2015-07-08 2015-07-07 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -2,244 6,475,213 -0.03 2.08 -4,679 13,500,819
2015-07-08 2015-07-07 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -2,856 8,241,181 -0.03 2.08 -5,955 17,182,862
2015-07-08 2015-07-07 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -3,476 6,477,457 -0.05 2.08 -7,247 13,505,498
2015-07-08 2015-07-07 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -4,424 8,244,037 -0.05 2.08 -9,224 17,188,817
2015-07-08 2015-07-07 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -15,928 6,480,933 -0.25 2.08 -33,130 13,480,341
2015-07-08 2015-07-07 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -20,272 8,248,461 -0.25 2.08 -42,166 17,156,799
2015-07-08 2015-07-06 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -67,577 6,496,861 -1.03 2.12 -143,371 13,783,740
2015-07-08 2015-07-06 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -86,007 8,268,733 -1.03 2.12 -182,472 17,542,944
2015-07-08 2015-07-06 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -16,689 6,564,438 -0.25 2.12 -35,362 13,909,388
2015-07-08 2015-07-06 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -21,240 8,354,740 -0.25 2.12 -45,005 17,702,859
2015-07-01 2015-07-01 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -4,664 6,581,127 -0.07 2.11 -9,841 13,886,178
2015-07-01 2015-07-01 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -5,936 8,375,980 -0.07 2.11 -12,525 17,673,318
2015-07-01 2015-07-01 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -14,624 6,585,791 -0.22 2.10 -30,735 13,841,357
2015-07-01 2015-07-01 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -18,612 8,381,916 -0.22 2.10 -39,117 17,616,273
2015-07-01 2015-06-30 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -136,170 6,600,415 -2.02 2.08 -283,887 13,760,545
2015-07-01 2015-06-30 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -173,307 8,400,528 -2.02 2.08 -361,310 17,513,421
2015-07-01 2015-06-30 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -69,914 3,388,846 -2.02 2.08 -145,757 7,065,066
2015-07-01 2015-06-30 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -82,300 6,736,585 -1.21 2.08 -170,962 13,993,908
2015-07-01 2015-06-30 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -104,745 8,573,835 -1.21 2.08 -217,587 17,810,427
2015-07-01 2015-06-30 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -42,255 3,458,760 -1.21 2.08 -87,776 7,184,882
2015-07-01 2015-06-29 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -21,784 6,818,885 -0.32 2.18 -47,406 14,839,258
2015-07-01 2015-06-29 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -27,726 8,678,580 -0.32 2.18 -60,337 18,886,326
2015-07-01 2015-06-29 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -11,185 3,501,015 -0.32 2.18 -24,341 7,618,909
2015-07-01 2015-06-26 4/A ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -79,586 6,840,669 -1.15 2.24 -178,098 15,308,049
2015-07-01 2015-06-26 4/A ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -101,291 8,706,306 -1.15 2.24 -226,669 19,482,972
2015-07-01 2015-06-26 4/A ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -33,627 3,512,200 -0.95 2.24 -75,251 7,859,601
2015-07-01 2015-06-26 4/A ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -51,755 6,920,255 -0.74 2.25 -116,490 15,576,110
2015-07-01 2015-06-26 4/A ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -65,870 8,807,597 -0.74 2.25 -148,260 19,824,139
2015-07-01 2015-06-26 4/A ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -22,405 3,545,827 -0.63 2.25 -50,429 7,980,947
2015-06-26 2015-06-26 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -79,586 6,853,826 -1.15 2.24 -178,098 15,337,492
2015-06-26 2015-06-26 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -101,291 8,723,052 -1.15 2.24 -226,669 19,520,446
2015-06-26 2015-06-26 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -33,627 3,518,297 -0.95 2.24 -75,251 7,873,245
2015-06-26 2015-06-26 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -38,598 6,933,412 -0.55 2.25 -86,876 15,605,724
2015-06-26 2015-06-26 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -49,124 8,824,343 -0.55 2.25 -110,568 19,861,831
2015-06-26 2015-06-26 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -16,308 3,551,924 -0.46 2.25 -36,706 7,994,671
2015-06-26 2015-06-25 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -37,919 6,972,010 -0.54 2.25 -85,318 15,687,022
2015-06-26 2015-06-25 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -48,260 8,873,467 -0.54 2.25 -108,585 19,965,301
2015-06-26 2015-06-25 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -16,021 3,568,232 -0.45 2.25 -36,047 8,028,522
2015-06-26 2015-06-25 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -27,085 7,009,929 -0.38 2.25 -60,941 15,772,340
2015-06-26 2015-06-25 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -34,471 8,921,727 -0.38 2.25 -77,560 20,073,886
2015-06-26 2015-06-25 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -11,444 3,584,253 -0.32 2.25 -25,749 8,064,569
2015-06-26 2015-06-24 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -27,164 7,037,014 -0.38 2.34 -63,466 16,441,280
2015-06-26 2015-06-24 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -34,572 8,956,198 -0.38 2.34 -80,774 20,925,261
2015-06-26 2015-06-24 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -11,477 3,595,697 -0.32 2.34 -26,815 8,400,986
2015-06-26 2015-06-24 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -29,214 7,064,178 -0.41 2.30 -67,192 16,247,609
2015-06-26 2015-06-24 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -37,181 8,990,770 -0.41 2.30 -85,516 20,678,771
2015-06-26 2015-06-24 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -12,344 3,607,174 -0.34 2.30 -28,391 8,296,500
2015-06-26 2015-06-24 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -41,245 7,093,392 -0.58 2.29 -94,418 16,238,193
2015-06-26 2015-06-24 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -52,494 9,027,951 -0.58 2.29 -120,169 20,666,785
2015-06-26 2015-06-24 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -17,427 3,619,518 -0.48 2.29 -39,894 8,285,801
2015-06-23 2015-06-23 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -67,475 7,134,637 -0.94 2.35 -158,499 16,759,262
2015-06-23 2015-06-23 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -85,877 9,080,445 -0.94 2.35 -201,725 21,329,965
2015-06-23 2015-06-23 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -28,510 3,636,945 -0.78 2.35 -66,970 8,543,184
2015-06-23 2015-06-22 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -65,479 7,202,112 -0.90 2.41 -157,569 17,331,162
2015-06-23 2015-06-22 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -83,338 9,166,322 -0.90 2.41 -200,545 22,057,837
2015-06-23 2015-06-22 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -27,666 3,665,455 -0.75 2.41 -66,575 8,820,551
2015-06-23 2015-06-19 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -52,518 7,267,591 -0.72 2.41 -126,337 17,482,917
2015-06-23 2015-06-19 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -66,842 9,249,660 -0.72 2.41 -160,795 22,250,982
2015-06-23 2015-06-19 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -22,190 3,693,121 -0.60 2.41 -53,380 8,884,172
2015-06-18 2015-06-18 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -1,447 7,320,109 -0.02 2.48 -3,589 18,153,870
2015-06-18 2015-06-18 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -1,842 9,316,502 -0.02 2.48 -4,568 23,104,925
2015-06-18 2015-06-18 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -611 3,715,311 -0.02 2.48 -1,515 9,213,971
2015-06-18 2015-06-18 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -76,728 7,321,556 -1.04 2.48 -189,948 18,125,244
2015-06-18 2015-06-18 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -97,654 9,318,344 -1.04 2.48 -241,752 23,068,492
2015-06-18 2015-06-18 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -32,419 3,715,922 -0.86 2.48 -80,256 9,199,137
2015-06-18 2015-06-17 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -19,889 7,398,284 -0.27 2.41 -47,839 17,795,093
2015-06-18 2015-06-17 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -25,313 9,415,998 -0.27 2.41 -60,885 22,648,300
2015-06-18 2015-06-17 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -8,403 3,748,341 -0.22 2.41 -20,212 9,015,885
2015-06-18 2015-06-16 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -43,506 7,418,173 -0.58 2.40 -104,506 17,819,193
2015-06-18 2015-06-16 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -55,372 9,441,311 -0.58 2.40 -133,009 22,678,973
2015-06-18 2015-06-16 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -18,382 3,756,744 -0.49 2.40 -44,155 9,024,075
2015-06-18 2015-06-16 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -35,915 7,461,679 -0.48 2.40 -86,322 17,934,145
2015-06-18 2015-06-16 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -45,710 9,496,683 -0.48 2.40 -109,864 22,825,278
2015-06-18 2015-06-16 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -15,175 3,775,126 -0.40 2.40 -36,473 9,073,515
2015-06-15 2015-06-15 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -22,973 3,790,301 -0.60 2.40 -55,144 9,098,239
2015-06-15 2015-06-15 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -5,267 3,813,274 -0.14 2.40 -12,641 9,151,858
2015-06-15 2015-06-15 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -1,568 3,818,541 -0.04 2.40 -3,771 9,183,591
2015-06-15 2015-06-15 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -54,370 7,497,594 -0.72 2.40 -130,510 17,997,225
2015-06-15 2015-06-15 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -69,198 9,542,393 -0.72 2.40 -166,103 22,905,560
2015-06-15 2015-06-15 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -12,467 7,551,964 -0.16 2.40 -29,921 18,124,714
2015-06-15 2015-06-15 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -15,866 9,611,591 -0.16 2.40 -38,078 23,067,818
2015-06-15 2015-06-15 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -3,710 7,564,431 -0.05 2.40 -8,923 18,192,457
2015-06-15 2015-06-15 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -4,722 9,627,457 -0.05 2.40 -11,356 23,154,034
2015-06-15 2015-06-12 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -44,010 7,568,141 -0.58 2.43 -106,874 18,378,474
2015-06-15 2015-06-12 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -56,012 9,632,179 -0.58 2.43 -136,020 23,390,783
2015-06-15 2015-06-12 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -18,551 7,612,151 -0.24 2.42 -44,986 18,459,466
2015-06-15 2015-06-12 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -18,551 7,612,151 -0.24 2.42 -44,986 18,459,466
2015-06-15 2015-06-12 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -23,611 9,688,191 -0.24 2.42 -57,257 23,493,863
2015-06-15 2015-06-12 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -23,611 9,688,191 -0.24 2.42 -57,257 23,493,863
2015-06-15 2015-06-12 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -18,595 3,820,109 -0.48 2.43 -45,156 9,276,753
2015-06-15 2015-06-12 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -7,838 3,838,704 -0.20 2.42 -19,007 9,308,857
2015-06-15 2015-06-12 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -7,838 3,838,704 -0.20 2.42 -19,007 9,308,857
2015-06-15 2015-06-11 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -67,627 7,649,253 -0.88 2.47 -166,782 18,864,588
2015-06-15 2015-06-11 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -86,071 9,735,413 -0.88 2.47 -212,268 24,009,476
2015-06-15 2015-06-11 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -58,251 7,716,880 -0.75 2.48 -144,445 19,135,547
2015-06-15 2015-06-11 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -74,137 9,821,484 -0.75 2.48 -183,838 24,354,334
2015-06-15 2015-06-11 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -28,574 3,854,380 -0.74 2.47 -70,469 9,505,672
2015-06-15 2015-06-11 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -24,612 3,882,954 -0.63 2.48 -61,030 9,628,561
2015-05-18 3 VNDA Vanda Pharmaceuticals Inc.
Common Stock
5,536,135
2015-05-18 3 VNDA Vanda Pharmaceuticals Inc.
Common Stock
6,558,316
2015-05-18 3 VNDA Vanda Pharmaceuticals Inc.
Common Stock
7,042,177
2015-05-18 3 VNDA Vanda Pharmaceuticals Inc.
Common Stock
5,536,135
2015-05-18 3 VNDA Vanda Pharmaceuticals Inc.
Common Stock
6,558,316
2015-05-18 3 VNDA Vanda Pharmaceuticals Inc.
Common Stock
7,042,177
2015-05-18 3 VNDA Vanda Pharmaceuticals Inc.
Common Stock
5,536,135
2015-05-18 3 VNDA Vanda Pharmaceuticals Inc.
Common Stock
6,558,316
2015-05-18 3 VNDA Vanda Pharmaceuticals Inc.
Common Stock
7,042,177
2015-05-18 3 VNDA Vanda Pharmaceuticals Inc.
Common Stock
5,536,135
2015-05-18 3 VNDA Vanda Pharmaceuticals Inc.
Common Stock
6,558,316
2015-05-18 3 VNDA Vanda Pharmaceuticals Inc.
Common Stock
7,042,177
2015-05-18 3 VNDA Vanda Pharmaceuticals Inc.
Common Stock
5,536,135
2015-05-18 3 VNDA Vanda Pharmaceuticals Inc.
Common Stock
6,558,316
2015-05-18 3 VNDA Vanda Pharmaceuticals Inc.
Common Stock
7,042,177
2015-05-18 3 VNDA Vanda Pharmaceuticals Inc.
Common Stock
5,536,135
2015-05-18 3 VNDA Vanda Pharmaceuticals Inc.
Common Stock
6,558,316
2015-05-18 3 VNDA Vanda Pharmaceuticals Inc.
Common Stock
7,042,177
2015-05-18 3 VNDA Vanda Pharmaceuticals Inc.
Common Stock
5,536,135
2015-05-18 3 VNDA Vanda Pharmaceuticals Inc.
Common Stock
6,558,316
2015-05-18 3 VNDA Vanda Pharmaceuticals Inc.
Common Stock
7,042,177
2015-05-13 3 ATRS ANTARES PHARMA, INC.
Common stock
29,353,449
2015-05-13 3 ATRS ANTARES PHARMA, INC.
Common stock
31,473,939
2015-05-13 3 ATRS ANTARES PHARMA, INC.
Common stock
25,485,884
2015-05-13 3 ATRS ANTARES PHARMA, INC.
Common stock
29,353,449
2015-05-13 3 ATRS ANTARES PHARMA, INC.
Common stock
31,473,939
2015-05-13 3 ATRS ANTARES PHARMA, INC.
Common stock
25,485,884
2015-05-13 3 ATRS ANTARES PHARMA, INC.
Common stock
29,353,449
2015-05-13 3 ATRS ANTARES PHARMA, INC.
Common stock
31,473,939
2015-05-13 3 ATRS ANTARES PHARMA, INC.
Common stock
25,485,884
2015-05-13 3 ATRS ANTARES PHARMA, INC.
Common stock
29,353,449
2015-05-13 3 ATRS ANTARES PHARMA, INC.
Common stock
31,473,939
2015-05-13 3 ATRS ANTARES PHARMA, INC.
Common stock
25,485,884
2015-05-13 3 ATRS ANTARES PHARMA, INC.
Common stock
29,353,449
2015-05-13 3 ATRS ANTARES PHARMA, INC.
Common stock
31,473,939
2015-05-13 3 ATRS ANTARES PHARMA, INC.
Common stock
25,485,884
2015-05-13 3 ATRS ANTARES PHARMA, INC.
Common stock
29,353,449
2015-05-13 3 ATRS ANTARES PHARMA, INC.
Common stock
31,473,939
2015-05-13 3 ATRS ANTARES PHARMA, INC.
Common stock
25,485,884
2015-05-13 3 ATRS ANTARES PHARMA, INC.
Common stock
29,353,449
2015-05-13 3 ATRS ANTARES PHARMA, INC.
Common stock
31,473,939
2015-05-13 3 ATRS ANTARES PHARMA, INC.
Common stock
25,485,884
2015-05-07 2015-05-05 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
U - Other -973,379 0 -100.00
2015-05-07 2015-05-05 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
U - Other -849,426 0 -100.00
2015-05-07 2015-05-05 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
U - Other -1,182,943 0 -100.00
2015-05-07 2015-05-05 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
U - Other -953,286 0 -100.00
2015-05-07 2015-05-05 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
U - Other -490,069 0 -100.00
2015-03-09 2015-03-06 4 EHTH eHealth, Inc.
Common Stock
S - Sale -742,029 1,062,874 -41.11 9.52 -7,064,116 10,118,560
2015-03-09 2015-03-06 4 EHTH eHealth, Inc.
Common Stock
S - Sale -600,544 859,141 -41.14 9.52 -5,717,179 8,179,022
2015-02-02 2015-01-29 4 AUXL AUXILIUM PHARMACEUTICALS INC
Common Stock
U - Other -3,469,974 0 -100.00
2015-02-02 2015-01-29 4 AUXL AUXILIUM PHARMACEUTICALS INC
Common Stock
U - Other -2,797,408 0 -100.00
2015-01-28 2015-01-28 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
P - Purchase 192,240 973,379 24.61 56.50 10,861,560 54,995,914
2015-01-28 2015-01-28 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
P - Purchase 167,760 849,426 24.61 56.50 9,478,440 47,992,569
2015-01-28 2015-01-28 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
P - Purchase 566,825 1,182,943 92.00 56.50 32,025,612 66,836,280
2015-01-28 2015-01-28 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
P - Purchase 458,175 953,286 92.54 56.50 25,886,888 53,860,659
2015-01-28 2015-01-28 4 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
P - Purchase 115,000 490,069 30.66 56.50 6,497,500 27,688,898
2015-01-16 2015-01-14 4 EHTH eHealth, Inc.
Common Stock
P - Purchase 420,280 1,804,903 30.35 20.45 8,594,726 36,910,266
2015-01-16 2015-01-14 4 EHTH eHealth, Inc.
Common Stock
P - Purchase 339,720 1,459,685 30.33 20.45 6,947,274 29,850,558
2015-01-16 2015-01-14 4 EHTH eHealth, Inc.
Common Stock
P - Purchase 132,720 1,384,623 10.60 19.84 2,632,501 27,463,997
2015-01-16 2015-01-14 4 EHTH eHealth, Inc.
Common Stock
P - Purchase 107,280 1,119,965 10.59 19.84 2,127,899 22,214,506
2014-12-24 3 VNDA Vanda Pharmaceuticals Inc.
Common Stock
4,588,361
2014-12-24 3 VNDA Vanda Pharmaceuticals Inc.
Common Stock
4,485,476
2014-12-24 3 VNDA Vanda Pharmaceuticals Inc.
Common Stock
5,252,554
2014-12-24 3 VNDA Vanda Pharmaceuticals Inc.
Common Stock
5,562,474
2014-12-24 3 VNDA Vanda Pharmaceuticals Inc.
Common Stock
4,588,361
2014-12-24 3 VNDA Vanda Pharmaceuticals Inc.
Common Stock
4,485,476
2014-12-24 3 VNDA Vanda Pharmaceuticals Inc.
Common Stock
5,252,554
2014-12-24 3 VNDA Vanda Pharmaceuticals Inc.
Common Stock
5,562,474
2014-12-24 3 VNDA Vanda Pharmaceuticals Inc.
Common Stock
4,588,361
2014-12-24 3 VNDA Vanda Pharmaceuticals Inc.
Common Stock
4,485,476
2014-12-24 3 VNDA Vanda Pharmaceuticals Inc.
Common Stock
5,252,554
2014-12-24 3 VNDA Vanda Pharmaceuticals Inc.
Common Stock
5,562,474
2014-12-24 3 VNDA Vanda Pharmaceuticals Inc.
Common Stock
4,588,361
2014-12-24 3 VNDA Vanda Pharmaceuticals Inc.
Common Stock
4,485,476
2014-12-24 3 VNDA Vanda Pharmaceuticals Inc.
Common Stock
5,252,554
2014-12-24 3 VNDA Vanda Pharmaceuticals Inc.
Common Stock
5,562,474
2014-12-24 3 VNDA Vanda Pharmaceuticals Inc.
Common Stock
4,588,361
2014-12-24 3 VNDA Vanda Pharmaceuticals Inc.
Common Stock
4,485,476
2014-12-24 3 VNDA Vanda Pharmaceuticals Inc.
Common Stock
5,252,554
2014-12-24 3 VNDA Vanda Pharmaceuticals Inc.
Common Stock
5,562,474
2014-12-24 3 VNDA Vanda Pharmaceuticals Inc.
Common Stock
4,588,361
2014-12-24 3 VNDA Vanda Pharmaceuticals Inc.
Common Stock
4,485,476
2014-12-24 3 VNDA Vanda Pharmaceuticals Inc.
Common Stock
5,252,554
2014-12-24 3 VNDA Vanda Pharmaceuticals Inc.
Common Stock
5,562,474
2014-12-24 3 VNDA Vanda Pharmaceuticals Inc.
Common Stock
4,588,361
2014-12-24 3 VNDA Vanda Pharmaceuticals Inc.
Common Stock
4,485,476
2014-12-24 3 VNDA Vanda Pharmaceuticals Inc.
Common Stock
5,252,554
2014-12-24 3 VNDA Vanda Pharmaceuticals Inc.
Common Stock
5,562,474
2014-12-24 3 VNDA Vanda Pharmaceuticals Inc.
Common Stock
4,588,361
2014-12-24 3 VNDA Vanda Pharmaceuticals Inc.
Common Stock
4,485,476
2014-12-24 3 VNDA Vanda Pharmaceuticals Inc.
Common Stock
5,252,554
2014-12-24 3 VNDA Vanda Pharmaceuticals Inc.
Common Stock
5,562,474
2014-12-24 2014-12-23 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
P - Purchase 20,580 1,674,781 1.24 14.48 297,998 24,250,829
2014-12-24 2014-12-23 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
P - Purchase 16,434 1,346,715 1.24 14.48 237,964 19,500,433
2014-12-24 2014-12-23 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
P - Purchase 13,900 1,654,201 0.85 14.30 198,770 23,655,074
2014-12-24 2014-12-23 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
P - Purchase 11,100 1,330,281 0.84 14.30 158,730 19,023,018
2014-12-24 2014-12-23 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
P - Purchase 11,120 1,640,301 0.68 14.33 159,350 23,505,513
2014-12-24 2014-12-23 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
P - Purchase 8,880 1,319,181 0.68 14.33 127,250 18,903,864
2014-12-24 2014-12-23 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
P - Purchase 13,900 1,629,181 0.86 14.50 201,550 23,623,124
2014-12-24 2014-12-23 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
P - Purchase 11,100 1,310,301 0.85 14.50 160,950 18,999,364
2014-12-24 2014-12-23 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
P - Purchase 16,680 1,615,281 1.04 14.48 241,526 23,389,269
2014-12-24 2014-12-23 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
P - Purchase 13,320 1,299,201 1.04 14.48 192,874 18,812,430
2014-12-24 2014-12-23 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
P - Purchase 13,900 1,598,601 0.88 14.23 197,797 22,748,092
2014-12-24 2014-12-23 4 VNDA Vanda Pharmaceuticals Inc.
Common Stock
P - Purchase 11,100 1,285,881 0.87 14.23 157,953 18,298,087
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3,324,172
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3,444,214
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3,565,221
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3,630,769
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3,730,242
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3,324,172
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3,444,214
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3,565,221
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3,630,769
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3,730,242
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3,324,172
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3,444,214
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3,565,221
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3,630,769
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3,730,242
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3,324,172
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3,444,214
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3,565,221
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3,630,769
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3,730,242
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3,324,172
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3,444,214
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3,565,221
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3,630,769
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3,730,242
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3,324,172
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3,444,214
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3,565,221
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3,630,769
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3,730,242
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3,324,172
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3,444,214
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3,565,221
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3,630,769
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3,730,242
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3,324,172
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3,444,214
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3,565,221
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3,630,769
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3,730,242
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3,324,172
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3,444,214
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3,565,221
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3,630,769
2014-12-22 3 ASPX Auspex Pharmaceuticals, Inc.
Common Stock
3,730,242
2014-10-01 2014-09-30 4 AUXL AUXILIUM PHARMACEUTICALS INC
1.50% Convertible Senior Notes due 2018
S - Sale 0 1,974,921.00
2014-10-01 2014-09-30 4 AUXL AUXILIUM PHARMACEUTICALS INC
1.50% Convertible Senior Notes due 2018
S - Sale 0 1,599,314.00
2014-10-01 2014-09-29 4 AUXL AUXILIUM PHARMACEUTICALS INC
1.50% Convertible Senior Notes due 2018
S - Sale 2,528,763.00
2014-10-01 2014-09-29 4 AUXL AUXILIUM PHARMACEUTICALS INC
1.50% Convertible Senior Notes due 2018
S - Sale 2,048,365.00
2014-09-25 2014-09-24 4 AUXL AUXILIUM PHARMACEUTICALS INC
1.50% Convertible Senior Notes due 2018
S - Sale 603,102.00
2014-09-25 2014-09-24 4 AUXL AUXILIUM PHARMACEUTICALS INC
1.50% Convertible Senior Notes due 2018
S - Sale 743,108.00
2014-09-25 2014-09-24 4 AUXL AUXILIUM PHARMACEUTICALS INC
1.50% Convertible Senior Notes due 2018
S - Sale 5,960,963.00
2014-09-25 2014-09-24 4 AUXL AUXILIUM PHARMACEUTICALS INC
1.50% Convertible Senior Notes due 2018
S - Sale 7,357,516.00
2014-09-25 2014-09-23 4 AUXL AUXILIUM PHARMACEUTICALS INC
1.50% Convertible Senior Notes due 2018
S - Sale 4,852,505.67
2014-09-25 2014-09-23 4 AUXL AUXILIUM PHARMACEUTICALS INC
1.50% Convertible Senior Notes due 2018
S - Sale 5,988,054.33
2014-08-11 2014-08-07 4 EHTH eHealth, Inc.
Common Stock
P - Purchase 1,731 1,251,903 0.14 21.05 36,438 26,352,558
2014-08-11 2014-08-07 4 EHTH eHealth, Inc.
Common Stock
P - Purchase 1,400 1,012,685 0.14 21.05 29,470 21,317,019
2014-08-06 2014-08-06 4 LOXO Loxo Oncology, Inc.
Series B Preferred Stock
C - Conversion -222,839 0 -100.00
2014-08-06 2014-08-06 4 LOXO Loxo Oncology, Inc.
Series B Preferred Stock
C - Conversion -279,051 0 -100.00
2014-08-06 2014-08-06 4 LOXO Loxo Oncology, Inc.
Common Stock
P - Purchase 77,256 296,125 35.30 13.05 1,008,191 3,864,431
2014-08-06 2014-08-06 4 LOXO Loxo Oncology, Inc.
Common Stock
P - Purchase 218,869 218,869 13.00 2,845,297 2,845,297
2014-08-06 2014-08-06 4 LOXO Loxo Oncology, Inc.
Common Stock
P - Purchase 62,400 239,300 35.27 13.05 814,320 3,122,865
2014-08-06 2014-08-06 4 LOXO Loxo Oncology, Inc.
Common Stock
P - Purchase 176,900 176,900 13.00 2,299,700 2,299,700
2014-08-06 2014-08-06 4 LOXO Loxo Oncology, Inc.
Common Stock
P - Purchase 246,631 469,470 110.68 13.00 3,206,203 6,103,110
2014-08-06 2014-08-06 4 LOXO Loxo Oncology, Inc.
Common Stock
P - Purchase 307,600 586,651 110.23 13.00 3,998,800 7,626,463
2014-08-06 2014-08-06 4 LOXO Loxo Oncology, Inc.
Common Stock
C - Conversion 222,839 222,839
2014-08-06 2014-08-06 4 LOXO Loxo Oncology, Inc.
Common Stock
C - Conversion 279,051 279,051
2014-08-05 2014-08-05 4 AAVL Avalanche Biotechnologies, Inc.
Series B Preferred Stock
C - Conversion -531,208 0 -100.00
2014-08-05 2014-08-05 4 AAVL Avalanche Biotechnologies, Inc.
Series B Preferred Stock
C - Conversion -147,410 0 -100.00
2014-08-05 2014-08-05 4 AAVL Avalanche Biotechnologies, Inc.
Series B Preferred Stock
C - Conversion -184,594 0 -100.00
2014-08-05 2014-08-05 4 AAVL Avalanche Biotechnologies, Inc.
Common Stock
P - Purchase 31,650 627,267 5.31 24.57 777,640 15,411,950
2014-08-05 2014-08-05 4 AAVL Avalanche Biotechnologies, Inc.
Common Stock
P - Purchase 49,981 595,617 9.16 26.35 1,316,999 15,694,508
2014-08-05 2014-08-05 4 AAVL Avalanche Biotechnologies, Inc.
Common Stock
P - Purchase 27,600 545,636 5.33 26.14 721,464 14,262,925
2014-08-05 2014-08-05 4 AAVL Avalanche Biotechnologies, Inc.
Common Stock
P - Purchase 12,400 518,036 2.45 27.54 341,496 14,266,711
2014-08-05 2014-08-05 4 AAVL Avalanche Biotechnologies, Inc.
Common Stock
P - Purchase 219,864 505,636 76.94 26.42 5,808,807 13,358,903
2014-08-05 2014-08-05 4 AAVL Avalanche Biotechnologies, Inc.
Common Stock
P - Purchase 18,700 285,772 7.00 25.79 482,273 7,370,060
2014-08-05 2014-08-05 4 AAVL Avalanche Biotechnologies, Inc.
Common Stock
P - Purchase 9,800 267,072 3.81 25.52 250,096 6,815,677
2014-08-05 2014-08-05 4 AAVL Avalanche Biotechnologies, Inc.
Common Stock
P - Purchase 201,972 257,272 365.23 25.41 5,132,109 6,537,282
2014-08-05 2014-08-05 4 AAVL Avalanche Biotechnologies, Inc.
Common Stock
P - Purchase 55,300 55,300 17.00 940,100 940,100
2014-08-05 2014-08-05 4 AAVL Avalanche Biotechnologies, Inc.
Common Stock
P - Purchase 25,600 507,200 5.32 24.57 628,992 12,461,904
2014-08-05 2014-08-05 4 AAVL Avalanche Biotechnologies, Inc.
Common Stock
P - Purchase 40,400 481,600 9.16 26.35 1,064,540 12,690,160
2014-08-05 2014-08-05 4 AAVL Avalanche Biotechnologies, Inc.
Common Stock
P - Purchase 22,400 441,200 5.35 26.14 585,536 11,532,968
2014-08-05 2014-08-05 4 AAVL Avalanche Biotechnologies, Inc.
Common Stock
P - Purchase 10,100 418,800 2.47 27.54 278,154 11,533,752
2014-08-05 2014-08-05 4 AAVL Avalanche Biotechnologies, Inc.
Common Stock
P - Purchase 177,700 408,700 76.93 26.42 4,694,834 10,797,854
2014-08-05 2014-08-05 4 AAVL Avalanche Biotechnologies, Inc.
Common Stock
P - Purchase 15,100 231,000 6.99 25.79 389,429 5,957,490
2014-08-05 2014-08-05 4 AAVL Avalanche Biotechnologies, Inc.
Common Stock
P - Purchase 7,900 215,900 3.80 25.52 201,608 5,509,768
2014-08-05 2014-08-05 4 AAVL Avalanche Biotechnologies, Inc.
Common Stock
P - Purchase 163,300 208,000 365.32 25.41 4,149,453 5,285,280
2014-08-05 2014-08-05 4 AAVL Avalanche Biotechnologies, Inc.
Common Stock
P - Purchase 44,700 44,700 17.00 759,900 759,900
2014-08-05 2014-08-05 4 AAVL Avalanche Biotechnologies, Inc.
Common Stock
P - Purchase 123,077 654,285 23.17 17.00 2,092,309 11,122,845
2014-08-05 2014-08-05 4 AAVL Avalanche Biotechnologies, Inc.
Common Stock
P - Purchase 34,223 181,633 23.22 17.00 581,791 3,087,761
2014-08-05 2014-08-05 4 AAVL Avalanche Biotechnologies, Inc.
Common Stock
P - Purchase 42,700 227,294 23.13 17.00 725,900 3,863,998
2014-08-05 2014-08-05 4 AAVL Avalanche Biotechnologies, Inc.
Common Stock
C - Conversion 531,208 531,208
2014-08-05 2014-08-05 4 AAVL Avalanche Biotechnologies, Inc.
Common Stock
C - Conversion 147,410 147,410
2014-08-05 2014-08-05 4 AAVL Avalanche Biotechnologies, Inc.
Common Stock
C - Conversion 184,594 184,594
2014-08-05 2014-08-05 4 EHTH eHealth, Inc.
Common Stock
P - Purchase 2,085 1,250,172 0.17 20.99 43,764 26,241,110
2014-08-05 2014-08-05 4 EHTH eHealth, Inc.
Common Stock
P - Purchase 1,685 1,011,285 0.17 20.99 35,368 21,226,872
2014-08-05 2014-08-04 4 EHTH eHealth, Inc.
Common Stock
P - Purchase 78,853 1,248,087 6.74 20.75 1,636,200 25,897,805
2014-08-05 2014-08-04 4 EHTH eHealth, Inc.
Common Stock
P - Purchase 7,122 1,169,234 0.61 20.40 145,289 23,852,374
2014-08-05 2014-08-04 4 EHTH eHealth, Inc.
Common Stock
P - Purchase 63,738 1,009,600 6.74 20.75 1,322,564 20,949,200
2014-08-05 2014-08-04 4 EHTH eHealth, Inc.
Common Stock
P - Purchase 5,757 945,862 0.61 20.40 117,443 19,295,585
2014-08-05 2014-08-01 4 EHTH eHealth, Inc.
Common Stock
P - Purchase 13,272 1,162,112 1.16 19.40 257,477 22,544,973
2014-08-05 2014-08-01 4 EHTH eHealth, Inc.
Common Stock
P - Purchase 80,904 1,148,840 7.58 19.04 1,540,412 21,873,914
2014-08-05 2014-08-01 4 EHTH eHealth, Inc.
Common Stock
P - Purchase 10,728 940,105 1.15 19.40 208,123 18,238,037
2014-08-05 2014-08-01 4 EHTH eHealth, Inc.
Common Stock
P - Purchase 65,396 929,377 7.57 19.04 1,245,140 17,695,338
2014-08-05 3 EHTH eHealth, Inc.
Common stock
2,795,898
2014-08-05 3 EHTH eHealth, Inc.
Common stock
2,999,853
2014-08-05 3 EHTH eHealth, Inc.
Common stock
2,795,898
2014-08-05 3 EHTH eHealth, Inc.
Common stock
2,999,853
2014-08-05 3 EHTH eHealth, Inc.
Common stock
2,795,898
2014-08-05 3 EHTH eHealth, Inc.
Common stock
2,999,853
2014-08-05 3 EHTH eHealth, Inc.
Common stock
2,795,898
2014-08-05 3 EHTH eHealth, Inc.
Common stock
2,999,853
2014-08-05 3 EHTH eHealth, Inc.
Common stock
2,795,898
2014-08-05 3 EHTH eHealth, Inc.
Common stock
2,999,853
2014-08-05 3 EHTH eHealth, Inc.
Common stock
2,795,898
2014-08-05 3 EHTH eHealth, Inc.
Common stock
2,999,853
2014-06-10 3 AUXL AUXILIUM PHARMACEUTICALS INC
Common Stock
9,064,790
2014-06-10 3 AUXL AUXILIUM PHARMACEUTICALS INC
Common Stock
9,737,356
2014-06-10 3 AUXL AUXILIUM PHARMACEUTICALS INC
Common Stock
9,064,790
2014-06-10 3 AUXL AUXILIUM PHARMACEUTICALS INC
Common Stock
9,737,356
2014-06-10 3 AUXL AUXILIUM PHARMACEUTICALS INC
Common Stock
9,064,790
2014-06-10 3 AUXL AUXILIUM PHARMACEUTICALS INC
Common Stock
9,737,356
2014-06-10 3 AUXL AUXILIUM PHARMACEUTICALS INC
Common Stock
9,064,790
2014-06-10 3 AUXL AUXILIUM PHARMACEUTICALS INC
Common Stock
9,737,356
2014-06-10 3 AUXL AUXILIUM PHARMACEUTICALS INC
Common Stock
9,064,790
2014-06-10 3 AUXL AUXILIUM PHARMACEUTICALS INC
Common Stock
9,737,356
2014-06-10 3 AUXL AUXILIUM PHARMACEUTICALS INC
Common Stock
9,064,790
2014-06-10 3 AUXL AUXILIUM PHARMACEUTICALS INC
Common Stock
9,737,356
P
Compra de mercado aberto ou privada de ativo não-derivativo ou derivativo
S
Venda de mercado aberto ou privada de ativo não-derivativo ou derivativo
A
Concessão, premiação, ou outra aquisição de ativos da empresa (como uma opção)
C
Conversão de derivativo
D
Venda ou transferência de ativos de volta para a empresa
F
Pagamento do preço de exercício ou responsabilidade fiscal utilizando parte dos ativos recebidos da empresa
G
Doação de ativos pelo ou para o insider
K
Swaps de capital e transações de hedge similares
M
Exercício ou conversão de ativo derivativo recebido da empresa (como uma opção)
V
Uma transação voluntariamente reportada no Formulário 4
J
Outro (acompanhado de uma nota explicativa descrevendo a transação)